Medical tech company spun off from National University of Singapore hits B round.
Clearbridge BioMedics, medical tech company spun off from National University of Singapore, has raised SG$9m ($7.2m) in its series B round. Vertex Venture, a venture capital subsidiary of Singapore state-owned investment company Temasek, led the B round, which also included VC firm BioVeda Capital, the government’s co-funding scheme, Spring Seeds Capital, Clearbridge Biomedical Sciences Accelerator,…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
